Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/29/2025

Contraindications for NSAID Treatment in Patients with History of Myocardial Infarction

Primary Contraindications

  • The American College of Cardiology recommends that NSAIDs are contraindicated in patients with a history of myocardial infarction due to significantly increased risk of mortality, reinfarction, heart failure, hypertension, and myocardial rupture 1, 2
  • Recent myocardial infarction: NSAIDs are absolutely contraindicated during hospitalization for acute MI and should be discontinued immediately upon presentation with STEMI 1, 3

Risk Stratification by NSAID Type

  • The American College of Cardiology states that COX-2 selective inhibitors (e.g., celecoxib) have the highest risk of cardiovascular events in patients with prior MI 2
  • Ibuprofen is associated with a moderate risk of cardiovascular events and also interferes with the cardioprotective effects of aspirin 4

Alternative Pain Management Approaches

  • The American College of Cardiology recommends a stepped-care approach for pain management in patients with history of MI, starting with first-line options such as acetaminophen, small doses of narcotics, and non-acetylated salicylates 4
  • COX-2 selective NSAIDs should only be considered when all other options have failed and only for the shortest possible duration at the lowest effective dose 2, 4

Monitoring Recommendations

  • The American College of Cardiology recommends using the lowest effective dose of NSAIDs for the shortest possible time and monitoring for signs of cardiac ischemia, heart failure exacerbation, hypertension, and bleeding 1, 2, 4, 5
  • Patients on antithrombotic therapy should be closely monitored for bleeding risk 5